Who is sponsoring NCT03268031?

NCT03268031 is sponsored by Sun Yat-sen University.

What drugs are being tested in NCT03268031?

Interventions in NCT03268031: Visual field and OCT tests.

What condition does NCT03268031 study?

NCT03268031 studies Artificial Intelligence, Glaucoma.

Is NCT03268031 still recruiting?

NCT03268031 is currently completed. Last updated 22 October 2020.

Last reviewed 2020-10-22 · How we verify

NCT03268031: AGE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Artificial Intelligence-assissted Glaucoma Evaluation

Completed Last updated 22 October 2020

What this trial tests

trial testing Visual field and OCT tests in Artificial Intelligence in 10,800 participants. Completed in 1 February 2020.

Timeline

15 August 2017

Primary endpoint
1 December 2019

1 February 2020

Quick facts

Lead sponsor	Sun Yat-sen University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	10,800
Start date	15 August 2017
Primary completion	1 December 2019
Estimated completion	1 February 2020
Sites	1 location across China

Drugs / interventions tested

Visual field and OCT tests

Conditions studied

Artificial Intelligence — all drugs for Artificial Intelligence →
Glaucoma — all drugs for Glaucoma →

Sponsor

Sun Yat-sen University

Who can join

Eligibility, any sex, with Artificial Intelligence or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glaucoma is currently the second leading cause of irreversible blindness in the world. Our study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Development and clinical deployment of a smartphone-based visual field deep learning system for glaucoma detection.
Li F, Song D, Chen H, Xiong J, et al · · 2020 · cited 38× · PMID 33043147 · DOI 10.1038/s41746-020-00329-9

Verify or expand the search:

Other recruiting trials for Artificial Intelligence

Currently open trials in the same condition.

NCT07257796 — Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score · recruiting
NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
NCT07261618 — AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection · active not recruiting
NCT07098884 — Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos · recruiting
NCT06978348 — Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology. · recruiting

Other Sun Yat-sen University trials

Trials by the same sponsor.

NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03268031 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
Last refreshed: 22 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03268031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing